Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
about
A Novel Prolyl Endopeptidase Inhibitor, JTP-4819 - Its Behavioral and Neurochemical Properties for the Treatment of Alzheimer's DiseaseHuperzine A for Alzheimer's diseaseHuperzine A for Alzheimer's diseaseMild cognitive impairment: pathology and mechanisms.Four decades of neurodegenerative disease research: how far we have come!Hippocampal Non-Theta-Contingent Eyeblink Classical Conditioning: A Model System for Neurobiological DysfunctionTau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective StrategiesProteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer's DiseaseNon-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease PathogenesisAlzheimer's disease: Targeting the Cholinergic SystemEffect of Estradiol on Neurotrophin Receptors in Basal Forebrain Cholinergic Neurons: Relevance for Alzheimer's DiseaseWhat can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseTyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer typeThe LIM-homeobox gene Islet-1 is required for the development of restricted forebrain cholinergic neuronsSelective vulnerability in Alzheimer's disease: amyloid precursor protein and p75(NTR) interactionGypsogenin derivatives: an unexpected class of inhibitors of cholinesterases.The Fall of Sleep K-Complex in Alzheimer DiseaseAllosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.Galantamine-induced amyloid-{beta} clearance mediated via stimulation of microglial nicotinic acetylcholine receptorsAlzheimer disease models and human neuropathology: similarities and differencesBlockade of muscarinic receptors impairs the retrieval of well-trained memory.Molecular recognition of rosmarinic acid from Salvia sclareoides extracts by acetylcholinesterase: a new binding site detected by NMR spectroscopy.Locus coeruleus cellular and molecular pathology during the progression of Alzheimer's disease.Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers.Donepezil: a clinical review of current and emerging indications.Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.Alterations in cognitive performance and affect-arousal state during fluctuations in motor function in Parkinson's disease.Reduction of arginine-vasopressin in the cerebral cortex in Alzheimer type senile dementia.The nucleus basalis of Meynert in 20 definite cases of Creutzfeldt-Jakob diseaseAltered Functional Connectivity of the Basal Nucleus of Meynert in Mild Cognitive Impairment: A Resting-State fMRI Study.Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's diseaseCholinesterase inhibitors: a therapeutic strategy for Alzheimer disease.Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.Role of Sleep Disturbance in the Trajectory of Alzheimer's Disease.Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease.Coeloglossum viride var. bracteatum extract protects against amyloid toxicity in rat prefrontal cortex neuronsActive components from Siberian ginseng (Eleutherococcus senticosus) for protection of amyloid β(25-35)-induced neuritic atrophy in cultured rat cortical neurons.Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects
P2860
Q21651042-DBA66ADA-ADC5-469D-975A-EE35270E43F6Q24243171-F3A396A0-7C40-41EE-AC78-8DC1A821C4A7Q24245024-D914E224-DA11-48B2-B099-511EDA96DEDDQ24631255-B5ECEA92-169B-496D-A934-06A7DD0FAE4CQ24645662-351C36E7-90EF-4C9C-AF69-72DB53F3FA1DQ26768146-8597A2EE-F59D-46E2-8999-EED372BD7094Q26769957-87B2C5F7-F9A3-4CF5-8856-B3071C812929Q26777933-4D2CA461-1B1C-46E2-985D-6277EBD6FA6FQ26822022-616A78CB-7ADC-43F4-9EAB-3F91FE193D10Q27027221-28D27EA2-7B00-4078-B9C6-8A757AEF6063Q28070135-2961260A-18DE-4EBD-AB5E-CD4BD7A862E8Q28071845-3CE5C2EB-BFA0-4C4E-B6E7-A606618AB3EAQ28083481-BA3EEEB6-1881-4DA1-91C9-E446231AB6BEQ28085513-6BC94215-EADB-425C-80DE-CEDCB22B845BQ28282747-8D5B77AC-CE64-45ED-B183-E4302BA44A59Q28504624-2A9AD631-1E3E-4C34-82CC-CE61FC8FB15AQ28574751-48486501-B80C-4624-851C-DF49E2908B8FQ30317236-6018E9EF-C12A-4180-A765-790391496416Q30366276-EB2AFA7A-5397-44B6-97FE-81E07039C92EQ30388923-29DA629C-83DF-47E9-8780-B4892AB36AECQ30497637-78CF7CE8-08CA-4A92-BBC2-BF053E5FB00DQ30499574-E11ECC5E-0D39-4D9B-9806-5491DA474264Q30576082-C5FA9EDF-8DE7-45B2-AD5D-8569BBE7EC30Q30608304-AE03B4B7-864C-4D28-B5A8-A64830D9F4C5Q30835713-D47F06F1-EF1D-417B-A72A-C98941BFA6FBQ31805904-162CB418-0145-4088-928E-F71647205F8EQ33150809-51DA9079-E644-4FBA-B939-A007F04F18D1Q33572429-99017DD4-732E-47BB-89D5-30E78D76A314Q33619721-74E5B569-302D-4581-91A4-5773833948EEQ33628814-9C915831-84E0-48C0-8E54-0945004A1583Q33629363-162C724D-D7CA-4C74-AA09-9098A3F681E1Q33634006-2073D5AC-F943-4E5A-B7AA-A084719C14B2Q33636322-FC073527-ECE4-4B7A-8AE4-9FF358B852D2Q33637687-6D5858BA-96AF-43C2-A61C-FD316EC0F314Q33639885-0B48B2E0-0475-4463-A804-43C789DAF901Q33662885-4756655E-5521-488B-BC70-AEE0076CCB51Q33759008-26DB0882-8DCA-4FD3-8195-082B8ED3AE11Q33764574-4607A15A-AA19-4FEE-B893-8AE0568BC4CEQ33814397-17913329-4BBF-41E0-90D1-5AFF4CD2008AQ33882427-F3BBB225-61E0-44D3-80A6-9D55C8D4378C
P2860
Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis.
description
1981 nî lūn-bûn
@nan
1981 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@ast
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@en
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@nl
type
label
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@ast
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@en
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@nl
prefLabel
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@ast
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@en
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@nl
P2093
P356
P1433
P1476
Alzheimer disease: evidence fo ...... eurons in the nucleus basalis.
@en
P2093
P304
P356
10.1002/ANA.410100203
P577
1981-08-01T00:00:00Z